UTHR - UNITED THERAPEUTICS Corp
IEX Last Trade
363.82
-0.270 -0.074%
Share volume: 3,375
Last Updated: Fri 27 Dec 2024 02:30:12 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.33%
PREVIOUS CLOSE
CHG
CHG%
$364.09
-0.27
-0.07%
Summary score
62%
Profitability
76%
Dept financing
5%
Liquidity
70%
Performance
60%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2020 - 30-Jun-2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
4.1%
Return on assets
3.91%
Return on sales
44.02%
Return on invested capital
7.6%
Total debt ratio
21.42%
Debt ratio change over timeo
3.24%
Current Ratio
7.2%
Quick Ratio
6.94%
Cash Position Ratio
5.9%
Short-term ratios 30-Jun-2023 - 30-Jun-2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
4.73%
Return on assets
4.63%
Return on sales
48.32%
Return on invested capital
10.58%
Total debt ratio
17.06%
Debt ratio change over timeo
0.67%
Current Ratio
4.3%
Quick Ratio
4.15%
Cash Position Ratio
3.58%
Last quarter ratios 30-Jun-2024
The data are presented for the financials results of the last quarter.
Return on equity
4.88%
Return on assets
4.76%
Return on sales
44.75%
Return on invested capital
12.24%
Total debt ratio
15.26%
Debt ratio change over time
0.98%
Current Ratio
4.35%
Quick Ratio
4.18%
Cash Position Ratio
3.57%
Performance ratios (change over 4 years) 30-Jun-2020 - 30-Jun-2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-41.48%
Return on assets
-53.49%
Return on sales
425.52%
Return on invested capital
4.28%
Total debt ratio
323.89%
Debt ratio change over time
3.24%
Current Ratio
132.37%
Quick Ratio
127.22%
Cash Position Ratio
108.08%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | UTHR | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 4.1% | 15.05% | 35.64% | 7.13% |
| Return on assets | 3.91% | 2.88% | 3.13% | 5.53% |
| Return on sales | 44.02% | 29.62% | 32.25% | 40.49% |
| Return on invested capital | 7.6% | 2.57% | 5.37% | 18.48% |
| Profitability | 56% | 44% | 65% | 78% |
| Total debt ratio | 21.42% | 90.48% | 91% | 25.78% |
| Debt ratio change over time | 3.24% | 326.95% | -8.44% | 1.18% |
| Dept financing | 6% | 50% | 25% | 7% |
| Current Ratio | 4.3% | 0.92% | 1.98% | 5.39% |
| Quick Ratio | 4.15% | 0.81% | 1.56% | 4.63% |
| Cash Position Ratio | 3.58% | 0.39% | 1.05% | 2.91% |
| Liquididy | 75% | 7% | 16% | 40% |
| Short-term ratios | UTHR | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 4.73% | 13.14% | 10.88% | 4.07% |
| Return on assets | 4.63% | 2.1% | 1.54% | 3.03% |
| Return on sales | 48.32% | 21.74% | 18.43% | 30.26% |
| Return on invested capital | 10.58% | 1.95% | 2.74% | 9.55% |
| Profitability | 84% | 52% | 45% | 62% |
| Total debt ratio | 17.06% | 92.68% | 93.24% | 21.84% |
| Debt ratio change over time | 0.67% | 51.04% | -101.54% | 1.43% |
| Dept financing | 5% | 50% | 25% | 7% |
| Current Ratio | 4.3% | 0.92% | 1.98% | 5.39% |
| Quick Ratio | 4.15% | 0.81% | 1.56% | 4.63% |
| Cash Position Ratio | 3.58% | 0.39% | 1.05% | 2.91% |
| Liquididy | 67% | 11% | 25% | 70% |